Literature DB >> 10648578

Predicting bacteremia and bacteremic mortality in liver transplant recipients.

N Singh1, D L Paterson, T Gayowski, M M Wagener, I R Marino.   

Abstract

Predictors of bacteremia and mortality in bacteremic liver transplant recipients were prospectively assessed. One hundred eleven consecutive episodes of fever or infections were documented in 59 patients over a 4-year period. Forty-nine percent (29 of 59 patients) of the patients had bacteremia, 39% (23 of 59 patients) had nonbacteremic infections, and 12% (7 of 59 patients) had fever of noninfectious cause. Primary (catheter-related) bacteremia (31%; 9 of 29 patients), pneumonia (24%; 7 of 29 patients), abdominal and/or biliary infections (14%; 4 of 29 patients), and wound infections (10%; 3 of 29 patients) were the predominant sources of bacteremia. Diabetes mellitus (odds ratio, 6.9; P =.03) and serum albumin level less than 3.0 mg/dL (odds ratio, 0.14; P =.02) were independently significant predictors of bacteremia compared with nonbacteremic infections. Mortality at 14 days was 28% (8 of 29 patients) in those with bacteremia compared with 4% (1 of 23 patients) in those with nonbacteremic infections and 0% (0 of 7) in patients with fever of noninfectious cause (P =.03). Intensive care unit stay at the time of bacteremia (100% v 47%; P =.005), absence of chills (0% v 53%; P =.005), lower temperature at the onset of bacteremia (99.2 degrees F v 101.5 degrees F; P =.009), lower maximum temperature during the course of bacteremia (99.3 degrees F v 102 degrees F, P =.008), greater serum bilirubin level (7.6 v 1.5 mg/dL; P =.024), presence of abnormal blood pressure (80% v 16%; P =. 0013), and greater prothrombin time (15.6 v 13.3 seconds; P =.013) were significantly predictive of greater mortality in the bacteremic patients. These data have implications for discerning the likelihood of bacteremia and initiation of empiric antibiotics pending cultures. Lack of febrile response in bacteremic liver transplant recipients portended a poorer outcome.

Entities:  

Mesh:

Year:  2000        PMID: 10648578     DOI: 10.1002/lt.500060112

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  21 in total

Review 1.  Bloodstream infections after solid-organ transplantation.

Authors:  Antonios Kritikos; Oriol Manuel
Journal:  Virulence       Date:  2016-01-14       Impact factor: 5.882

2.  Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver-kidney transplant recipients.

Authors:  Masahiko Yazawa; Orsolya Cseprekal; Ryan A Helmick; Manish Talwar; Vasanthi Balaraman; Pradeep S B Podila; Sallyanne Fossey; Sanjaya K Satapathy; James D Eason; Miklos Z Molnar
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

3.  Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost.

Authors:  Patrick G Northup; Michael M Abecassis; Michael J Englesbe; Jean C Emond; Vanessa D Lee; George J Stukenborg; Lan Tong; Carl L Berg
Journal:  Liver Transpl       Date:  2009-02       Impact factor: 5.799

4.  Infectious Complications After Liver Transplantation.

Authors:  Maria Del Pilar Hernandez; Paul Martin; Jacques Simkins
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-11

Review 5.  Bacterial infection after liver transplantation.

Authors:  Sang Il Kim
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

6.  Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients.

Authors:  Christian E Oberkofler; Philipp Dutkowski; Reto Stocker; Reto A Schuepbach; John F Stover; Pierre-Alain Clavien; Markus Béchir
Journal:  Crit Care       Date:  2010-06-15       Impact factor: 9.097

7.  Staphylococcus aureus bacteremias following liver transplantation: a clinical analysis of 20 cases.

Authors:  Jiandang Zhou; Hui Huang; Shan Liu; Ping Yu; Qiquan Wan
Journal:  Ther Clin Risk Manag       Date:  2015-06-12       Impact factor: 2.423

8.  Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation.

Authors:  Kuo-Hua Lin; Jien-Wei Liu; Chao-Long Chen; Shih-Hor Wang; Chih-Che Lin; Yueh-Wei Liu; Chee-Chien Yong; Ting-Lung Lin; Wei-Feng Li; Tsung-Hui Hu; Chih-Chi Wang
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

9.  Epidemiology and clinical features of post-transplant bloodstream infection: an analysis of 222 consecutive liver transplant recipients.

Authors:  Hyun Kyung Kim; Yong Keun Park; Hee-Jung Wang; Bong Wan Kim; So Youn Shin; Seung-Kwan Lim; Young Hwa Choi
Journal:  Infect Chemother       Date:  2013-09-27

10.  Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients.

Authors:  Sang Il Kim; Youn Jeong Kim; Yoon Hee Jun; Seong Heon Wie; Yang Ree Kim; Jong Young Choi; Seung Kyu Yoon; In Sung Moon; Dong Goo Kim; Myung Duk Lee; Moon Won Kang
Journal:  Yonsei Med J       Date:  2009-02-24       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.